Ganot Ilan — SEC insider filings

SEC reporting owner CIK 1727460. 35 insider filings on record with FilingPulse; latest filed 2026-10-26.

Transaction summary — filings shown

Covers all 35 filings on record, filed 2020-08-14 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Solid Biosciences Inc. (SLDB)Director35—18 legs · 32,981 sh · $190,38168

Insider filings — Ganot Ilan

FiledFormIssuerReported transactionsSource
2026-10-264Solid Biosciences Inc. (SLDB)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2026-06-114Solid Biosciences Inc. (SLDB)Grant/award (A): 77,500 (derivative) @ $0EDGAR
2026-02-184Solid Biosciences Inc. (SLDB)Option exercise (M): 4,861 · Sale (S): 2,658 @ $5.82 · Option exercise (M): 4,861 (derivative) @ $0EDGAR
2026-02-064Solid Biosciences Inc. (SLDB)Sale (S): 7,205 @ $6.44EDGAR
2026-02-024Solid Biosciences Inc. (SLDB)Option exercise (M): 15,000 · Grant/award (A): 70,900 (derivative) @ $0 · Grant/award (A): 35,450 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-01-304Solid Biosciences Inc. (SLDB)Option exercise (M): 389 · Sale (S): 191 @ $6.59 · Option exercise (M): 3,884 · Option exercise (M): 389 (derivative) @ $0 · Option exercise (M): 3,884 (derivative) @ $0EDGAR
2026-01-064Solid Biosciences Inc. (SLDB)Option exercise (M): 2,994 · Sale (S): 1,053 @ $5.43 · Option exercise (M): 2,994 (derivative) @ $0EDGAR
2025-11-134Solid Biosciences Inc. (SLDB)Sale (S): 3,278 @ $4.12EDGAR
2025-08-184Solid Biosciences Inc. (SLDB)Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 18,750 (derivative) @ $0EDGAR
2025-06-134Solid Biosciences Inc. (SLDB)Grant/award (A): 77,500 (derivative) @ $0EDGAR
2025-02-184Solid Biosciences Inc. (SLDB)Option exercise (M): 4,861 · Sale (S): 1,711 @ $3.96 · Option exercise (M): 4,861 (derivative) @ $0EDGAR
2025-02-114Solid Biosciences Inc. (SLDB)Grant/award (A): 60,000 (derivative) @ $0EDGAR
2025-01-294Solid Biosciences Inc. (SLDB)Option exercise (M): 388 · Sale (S): 144 @ $3.11 · Option exercise (M): 3,883 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0EDGAR
2025-01-074Solid Biosciences Inc. (SLDB)Option exercise (M): 2,994 · Sale (S): 1,056 @ $4.31 · Option exercise (M): 2,994 (derivative) @ $0EDGAR
2024-06-134Solid Biosciences Inc. (SLDB)Grant/award (A): 34,400 (derivative) @ $0EDGAR
2024-05-064Solid Biosciences Inc. (SLDB)Option exercise (M): 1,553 · Sale (S): 462 @ $10.33 · Option exercise (M): 1,553 (derivative) @ $0EDGAR
2024-02-164Solid Biosciences Inc. (SLDB)Grant/award (A): 19,444 (derivative) @ $0EDGAR
2024-01-304Solid Biosciences Inc. (SLDB)Option exercise (M): 388 · Sale (S): 139 @ $7.99 · Option exercise (M): 3,883 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0EDGAR
2024-01-054Solid Biosciences Inc. (SLDB)Option exercise (M): 2,993 · Sale (S): 1,142 @ $5.30 · Option exercise (M): 2,993 (derivative) @ $0EDGAR
2023-12-054Solid Biosciences Inc. (SLDB)Option exercise (M): 1,583 · Option exercise (M): 1,583 (derivative) @ $0EDGAR
2023-09-064Solid Biosciences Inc. (SLDB)Option exercise (M): 1,583 · Option exercise (M): 1,583 (derivative) @ $0EDGAR
2023-06-084Solid Biosciences Inc. (SLDB)Option exercise (M): 1,553 · Sale (S): 487 @ $4.85 · Option exercise (M): 1,583 · Option exercise (M): 1,553 (derivative) @ $0 · Option exercise (M): 1,583 (derivative) @ $0 · Grant/award (A): 9,650 (derivative) @ $0EDGAR
2023-03-064Solid Biosciences Inc. (SLDB)Option exercise (M): 1,584 · Option exercise (M): 1,584 (derivative) @ $0EDGAR
2023-01-314Solid Biosciences Inc. (SLDB)Option exercise (M): 388 · Sale (S): 141 @ $7.49 · Option exercise (M): 3,883 · Sale (S): 1,382 @ $7.49 · Option exercise (M): 388 (derivative) @ $0 · Option exercise (M): 3,883 (derivative) @ $0EDGAR
2023-01-054Solid Biosciences Inc. (SLDB)Grant/award (A): 23,950 (derivative) @ $0 · Grant/award (A): 11,975 (derivative) @ $0EDGAR
2022-12-054Solid Biosciences Inc. (SLDB)Grant/award (A): 13,333 (derivative) @ $0 · Grant/award (A): 6,333 (derivative) @ $0EDGAR
2022-05-044Solid Biosciences Inc. (SLDB)Grant/award (A): 46,600 (derivative) @ $0EDGAR
2022-03-084Solid Biosciences Inc. (SLDB)Sale (S): 463 @ $1.12EDGAR
2022-01-314Solid Biosciences Inc. (SLDB)Grant/award (A): 466,000 (derivative) @ $0 · Grant/award (A): 233,000 (derivative) @ $0 · Grant/award (A): 46,400 (derivative) @ $0 · Grant/award (A): 23,300 (derivative) @ $0EDGAR
2021-02-164Solid Biosciences Inc. (SLDB)Sale (S): 457 @ $7.66EDGAR
2021-01-294Solid Biosciences Inc. (SLDB)Option exercise (M): 35,500 · Sale (S): 10,713 @ $6.14 · Option exercise (M): 35,500 (derivative) @ $0EDGAR
2021-01-274Solid Biosciences Inc. (SLDB)Grant/award (A): 438,000 (derivative) @ $0 · Grant/award (A): 8,100 (derivative) @ $0EDGAR
2020-12-144Solid Biosciences Inc. (SLDB)Grant/award (A): 27,027 @ $3.70EDGAR
2020-09-144/ASolid Biosciences Inc. (SLDB)Grant/award (A): 1,350 (derivative) @ $0EDGAR
2020-08-144Solid Biosciences Inc. (SLDB)Option exercise (M): 800 · Sale (S): 299 @ $2.44 · Option exercise (M): 800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1727460 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs